Stockreport

MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance

MaxCyte, Inc.  (MXCT) 
PDF ROCKVILLE, Md., Dec. 08, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading cell-engineering focused company providing enabling platform tech [Read more]